Matthew Scribner - Inogen Insider

INGN -- USA Stock  

USD 255.98  7.90  2.99%

Mr. Matthew Scribner is no longer Executive Vice President Operations of Inogen, Inc., effective September 17, 2018. He has served as our Executive Vice President, Operations since March 2014. Prior to serving this position, Mr. Scribner served as our Vice President, Operations from 2008 until March 2014, the Director of Manufacturing from 2007 to 2008 and the Director of Supply Chain from 2004 to 2007. From 1998 to 2004, Mr. Scribner worked for Computer Motion, a manufacturer of surgical robots that was acquired by Intuitive Surgical, in various executive capacities, including as a Manufacturing Manager and as a Project Manager. From 1989 to 2013, Mr. Scribner served in the United States Navy as a helicopter pilot, on both active duty and as a reservist. He was mobilized and deployed to Iraq in 2003 to fly in support of Operation Iraqi Freedom. He achieved the rank of Commander and retired from the U.S. Navy in July 2013. Mr. Scribner received a BS degree in Ocean Engineering from the United States Naval Academy
Age: 49  President Since 2014  MBA    
Scribner also received an MBA from the University of San Diego.

Management Efficiency

The company has return on total asset (ROA) of 7.99 % which means that it generated profit of $7.99 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 13.53 % meaning that it created $13.53 on every $100 dollars invested by stockholders.

Similar Executives

Showing few of many executives


Huimin WangEdwards Lifesciences Corporatio
Robert CardonDynatronics Corporation
David EricksonEdwards Lifesciences Corporatio
Stephen OklandSecond Sight Medical Products
JeanLuc LemercierEdwards Lifesciences Corporatio
Bernard ZovighianEdwards Lifesciences Corporatio
Peter GearyEncision
David JacquesSecond Sight Medical Products
Douglas SampsonDynatronics Corporation
Frank VandeputteSecond Sight Medical Products
Anthony MosesSecond Sight Medical Products
Brian BakerDynatronics Corporation
Brad GreathouseEncision
Thomas GephartDynatronics Corporation
Steven OklandSecond Sight Medical Products
Catherine SzymanEdwards Lifesciences Corporatio

Entity Summary

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 770 people.Inogen (INGN) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 770 people. Inogen is listed under Medical Equipment category by Fama And French industry classification.

Inogen Leadership Team

Scott Beardsley, Director
Byron Myers, Co-Founder and VP of Marketing
Raymond Huggenberger, CEO and Director
Heath Lukatch, Independent Chairman of the Board
Heather Rider, Director
Loren McFarland, Independent Director
Scott Greer, Independent Director
Benjamin AndersonRay, Independent Director
Matthew Scribner, Executive Vice President - Operations
Alison Bauerlein, Co-Founder, CFO, Principal Accounting Officer, Executive VP of Fin., Treasurer and Secretary
Scott Wilkinson, Pres and COO
Brenton Taylor, Co-Founder and Executive VP of Engineering

Stock Performance Indicators

Did you try this?

Run Portfolio Center Now


Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Portfolio Center

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.